aluates Reports

$ 0.0

Automative

Global Aβ Monoclonal Antibody Drug Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-23U15312

Global Aβ Monoclonal Antibody Drug Market Research Report 2023

BUY CHAPTERS

Global Aβ Monoclonal Antibody Drug Market Research Report 2024

Code: QYRE-Auto-23U15312

Report

August 2024

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eisai Co Ltd

Biogen

Eli Lilly & Co

Aβ Monoclonal Antibody Drug Market

Aβ monoclonal antibody drugs are a type of drug used to treat Alzheimer's disease. Their function is to target the accumulation and deposition of β-amyloid protein (Aβ, or β-amyloid precursor protein). Slow or stop the progression of the disease.

Alzheimer's disease is a neurodegenerative disease, one of its main characteristics is the abnormal deposition of Aβ protein in the brain, forming β-amyloid plaques between neurons. These plaques are associated with cognitive decline and neuronal damage, so researchers seek to develop drugs to interfere with Aβ accumulation in the hope of slowing or curing Alzheimer's disease.

The global Aβ Monoclonal Antibody Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Aβ Monoclonal Antibody Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Aβ Monoclonal Antibody Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Aβ Monoclonal Antibody Drug include Eisai, Biogen and Eli Lilly & Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Aβ Monoclonal Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aβ Monoclonal Antibody Drug.

Report Scope

The Aβ Monoclonal Antibody Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aβ Monoclonal Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aβ Monoclonal Antibody Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Aβ Monoclonal Antibody Drug Market Report

Report Metric	Details
Report Name	Aβ Monoclonal Antibody Drug Market
Segment by Type	Aducanumab Lecanemab Donanemab
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eisai, Biogen, Eli Lilly & Co.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aβ Monoclonal Antibody Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aβ Monoclonal Antibody Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Aβ Monoclonal Antibody Drug Market report?

Ans: The main players in the Aβ Monoclonal Antibody Drug Market are Eisai, Biogen, Eli Lilly & Co.

What are the Application segmentation covered in the Aβ Monoclonal Antibody Drug Market report?

Ans: The Applications covered in the Aβ Monoclonal Antibody Drug Market report are Hospital, Clinic

What are the Type segmentation covered in the Aβ Monoclonal Antibody Drug Market report?

Ans: The Types covered in the Aβ Monoclonal Antibody Drug Market report are Aducanumab, Lecanemab, Donanemab

1 Aβ Monoclonal Antibody Drug Market Overview

1.1 Product Overview and Scope of Aβ Monoclonal Antibody Drug

1.2 Aβ Monoclonal Antibody Drug Segment by Type

1.2.1 Global Aβ Monoclonal Antibody Drug Market Value Comparison by Type (2024-2030)

1.2.2 Aducanumab

1.2.3 Lecanemab

1.2.4 Donanemab

1.3 Aβ Monoclonal Antibody Drug Segment by Application

1.3.1 Global Aβ Monoclonal Antibody Drug Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Aβ Monoclonal Antibody Drug Market Size Estimates and Forecasts

1.4.1 Global Aβ Monoclonal Antibody Drug Revenue 2019-2030

1.4.2 Global Aβ Monoclonal Antibody Drug Sales 2019-2030

1.4.3 Global Aβ Monoclonal Antibody Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Aβ Monoclonal Antibody Drug Market Competition by Manufacturers

2.1 Global Aβ Monoclonal Antibody Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Aβ Monoclonal Antibody Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Aβ Monoclonal Antibody Drug Average Price by Manufacturers (2019-2024)

2.4 Global Aβ Monoclonal Antibody Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Aβ Monoclonal Antibody Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Aβ Monoclonal Antibody Drug, Product Type & Application

2.7 Aβ Monoclonal Antibody Drug Market Competitive Situation and Trends

2.7.1 Aβ Monoclonal Antibody Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Aβ Monoclonal Antibody Drug Players Market Share by Revenue

2.7.3 Global Aβ Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Aβ Monoclonal Antibody Drug Retrospective Market Scenario by Region

3.1 Global Aβ Monoclonal Antibody Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Aβ Monoclonal Antibody Drug Global Aβ Monoclonal Antibody Drug Sales by Region: 2019-2030

3.2.1 Global Aβ Monoclonal Antibody Drug Sales by Region: 2019-2024

3.2.2 Global Aβ Monoclonal Antibody Drug Sales by Region: 2025-2030

3.3 Global Aβ Monoclonal Antibody Drug Global Aβ Monoclonal Antibody Drug Revenue by Region: 2019-2030

3.3.1 Global Aβ Monoclonal Antibody Drug Revenue by Region: 2019-2024

3.3.2 Global Aβ Monoclonal Antibody Drug Revenue by Region: 2025-2030

3.4 North America Aβ Monoclonal Antibody Drug Market Facts & Figures by Country

3.4.1 North America Aβ Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Aβ Monoclonal Antibody Drug Sales by Country (2019-2030)

3.4.3 North America Aβ Monoclonal Antibody Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Aβ Monoclonal Antibody Drug Market Facts & Figures by Country

3.5.1 Europe Aβ Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Aβ Monoclonal Antibody Drug Sales by Country (2019-2030)

3.5.3 Europe Aβ Monoclonal Antibody Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Aβ Monoclonal Antibody Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Aβ Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Aβ Monoclonal Antibody Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Aβ Monoclonal Antibody Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Aβ Monoclonal Antibody Drug Market Facts & Figures by Country

3.7.1 Latin America Aβ Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Aβ Monoclonal Antibody Drug Sales by Country (2019-2030)

3.7.3 Latin America Aβ Monoclonal Antibody Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Aβ Monoclonal Antibody Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Aβ Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Aβ Monoclonal Antibody Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Aβ Monoclonal Antibody Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Aβ Monoclonal Antibody Drug Sales by Type (2019-2030)

4.1.1 Global Aβ Monoclonal Antibody Drug Sales by Type (2019-2024)

4.1.2 Global Aβ Monoclonal Antibody Drug Sales by Type (2025-2030)

4.1.3 Global Aβ Monoclonal Antibody Drug Sales Market Share by Type (2019-2030)

4.2 Global Aβ Monoclonal Antibody Drug Revenue by Type (2019-2030)

4.2.1 Global Aβ Monoclonal Antibody Drug Revenue by Type (2019-2024)

4.2.2 Global Aβ Monoclonal Antibody Drug Revenue by Type (2025-2030)

4.2.3 Global Aβ Monoclonal Antibody Drug Revenue Market Share by Type (2019-2030)

4.3 Global Aβ Monoclonal Antibody Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Aβ Monoclonal Antibody Drug Sales by Application (2019-2030)

5.1.1 Global Aβ Monoclonal Antibody Drug Sales by Application (2019-2024)

5.1.2 Global Aβ Monoclonal Antibody Drug Sales by Application (2025-2030)

5.1.3 Global Aβ Monoclonal Antibody Drug Sales Market Share by Application (2019-2030)

5.2 Global Aβ Monoclonal Antibody Drug Revenue by Application (2019-2030)

5.2.1 Global Aβ Monoclonal Antibody Drug Revenue by Application (2019-2024)

5.2.2 Global Aβ Monoclonal Antibody Drug Revenue by Application (2025-2030)

5.2.3 Global Aβ Monoclonal Antibody Drug Revenue Market Share by Application (2019-2030)

5.3 Global Aβ Monoclonal Antibody Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Eisai

6.1.1 Eisai Corporation Information

6.1.2 Eisai Description and Business Overview

6.1.3 Eisai Aβ Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Eisai Aβ Monoclonal Antibody Drug Product Portfolio

6.1.5 Eisai Recent Developments/Updates

6.2 Biogen

6.2.1 Biogen Corporation Information

6.2.2 Biogen Description and Business Overview

6.2.3 Biogen Aβ Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Biogen Aβ Monoclonal Antibody Drug Product Portfolio

6.2.5 Biogen Recent Developments/Updates

6.3 Eli Lilly & Co.

6.3.1 Eli Lilly & Co. Corporation Information

6.3.2 Eli Lilly & Co. Description and Business Overview

6.3.3 Eli Lilly & Co. Aβ Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Eli Lilly & Co. Aβ Monoclonal Antibody Drug Product Portfolio

6.3.5 Eli Lilly & Co. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Aβ Monoclonal Antibody Drug Industry Chain Analysis

7.2 Aβ Monoclonal Antibody Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Aβ Monoclonal Antibody Drug Production Mode & Process

7.4 Aβ Monoclonal Antibody Drug Sales and Marketing

7.4.1 Aβ Monoclonal Antibody Drug Sales Channels

7.4.2 Aβ Monoclonal Antibody Drug Distributors

7.5 Aβ Monoclonal Antibody Drug Customers

8 Aβ Monoclonal Antibody Drug Market Dynamics

8.1 Aβ Monoclonal Antibody Drug Industry Trends

8.2 Aβ Monoclonal Antibody Drug Market Drivers

8.3 Aβ Monoclonal Antibody Drug Market Challenges

8.4 Aβ Monoclonal Antibody Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eisai Co Ltd

Biogen

Eli Lilly & Co

List of Tables

Table 1. Global Aβ Monoclonal Antibody Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Aβ Monoclonal Antibody Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Aβ Monoclonal Antibody Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Aβ Monoclonal Antibody Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Aβ Monoclonal Antibody Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Aβ Monoclonal Antibody Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Aβ Monoclonal Antibody Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Aβ Monoclonal Antibody Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Aβ Monoclonal Antibody Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Aβ Monoclonal Antibody Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Aβ Monoclonal Antibody Drug, Product Type & Application

Table 12. Global Key Manufacturers of Aβ Monoclonal Antibody Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Aβ Monoclonal Antibody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aβ Monoclonal Antibody Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Aβ Monoclonal Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Aβ Monoclonal Antibody Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Aβ Monoclonal Antibody Drug Sales Market Share by Region (2019-2024)

Table 19. Global Aβ Monoclonal Antibody Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Aβ Monoclonal Antibody Drug Sales Market Share by Region (2025-2030)

Table 21. Global Aβ Monoclonal Antibody Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Aβ Monoclonal Antibody Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Aβ Monoclonal Antibody Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Aβ Monoclonal Antibody Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Aβ Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Aβ Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Aβ Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Aβ Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Aβ Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Aβ Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Aβ Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Aβ Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Aβ Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Aβ Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Aβ Monoclonal Antibody Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Aβ Monoclonal Antibody Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Aβ Monoclonal Antibody Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Aβ Monoclonal Antibody Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Aβ Monoclonal Antibody Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Aβ Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Aβ Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Aβ Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Aβ Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Aβ Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Aβ Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Aβ Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Aβ Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Aβ Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Aβ Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Aβ Monoclonal Antibody Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Aβ Monoclonal Antibody Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Aβ Monoclonal Antibody Drug Sales Market Share by Type (2019-2024)

Table 53. Global Aβ Monoclonal Antibody Drug Sales Market Share by Type (2025-2030)

Table 54. Global Aβ Monoclonal Antibody Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Aβ Monoclonal Antibody Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Aβ Monoclonal Antibody Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Aβ Monoclonal Antibody Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Aβ Monoclonal Antibody Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global Aβ Monoclonal Antibody Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global Aβ Monoclonal Antibody Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Aβ Monoclonal Antibody Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Aβ Monoclonal Antibody Drug Sales Market Share by Application (2019-2024)

Table 63. Global Aβ Monoclonal Antibody Drug Sales Market Share by Application (2025-2030)

Table 64. Global Aβ Monoclonal Antibody Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Aβ Monoclonal Antibody Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Aβ Monoclonal Antibody Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Aβ Monoclonal Antibody Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Aβ Monoclonal Antibody Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global Aβ Monoclonal Antibody Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Eisai Corporation Information

Table 71. Eisai Description and Business Overview

Table 72. Eisai Aβ Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Eisai Aβ Monoclonal Antibody Drug Product

Table 74. Eisai Recent Developments/Updates

Table 75. Biogen Corporation Information

Table 76. Biogen Description and Business Overview

Table 77. Biogen Aβ Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Biogen Aβ Monoclonal Antibody Drug Product

Table 79. Biogen Recent Developments/Updates

Table 80. Eli Lilly & Co. Corporation Information

Table 81. Eli Lilly & Co. Description and Business Overview

Table 82. Eli Lilly & Co. Aβ Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Eli Lilly & Co. Aβ Monoclonal Antibody Drug Product

Table 84. Eli Lilly & Co. Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Aβ Monoclonal Antibody Drug Distributors List

Table 88. Aβ Monoclonal Antibody Drug Customers List

Table 89. Aβ Monoclonal Antibody Drug Market Trends

Table 90. Aβ Monoclonal Antibody Drug Market Drivers

Table 91. Aβ Monoclonal Antibody Drug Market Challenges

Table 92. Aβ Monoclonal Antibody Drug Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Aβ Monoclonal Antibody Drug

Figure 2. Global Aβ Monoclonal Antibody Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Aβ Monoclonal Antibody Drug Market Share by Type in 2023 & 2030

Figure 4. Aducanumab Product Picture

Figure 5. Lecanemab Product Picture

Figure 6. Donanemab Product Picture

Figure 7. Global Aβ Monoclonal Antibody Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Aβ Monoclonal Antibody Drug Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Global Aβ Monoclonal Antibody Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Aβ Monoclonal Antibody Drug Market Size (2019-2030) & (US$ Million)

Figure 13. Global Aβ Monoclonal Antibody Drug Sales (2019-2030) & (K Units)

Figure 14. Global Aβ Monoclonal Antibody Drug Average Price (US$/Unit) & (2019-2030)

Figure 15. Aβ Monoclonal Antibody Drug Report Years Considered

Figure 16. Aβ Monoclonal Antibody Drug Sales Share by Manufacturers in 2023

Figure 17. Global Aβ Monoclonal Antibody Drug Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Aβ Monoclonal Antibody Drug Players: Market Share by Revenue in 2023

Figure 19. Aβ Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Aβ Monoclonal Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Aβ Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)

Figure 22. North America Aβ Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)

Figure 23. United States Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Aβ Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)

Figure 26. Europe Aβ Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)

Figure 27. Germany Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Aβ Monoclonal Antibody Drug Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Aβ Monoclonal Antibody Drug Revenue Market Share by Region (2019-2030)

Figure 34. China Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Aβ Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)

Figure 42. Latin America Aβ Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Aβ Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Aβ Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Aβ Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Aβ Monoclonal Antibody Drug by Type (2019-2030)

Figure 52. Global Revenue Market Share of Aβ Monoclonal Antibody Drug by Type (2019-2030)

Figure 53. Global Aβ Monoclonal Antibody Drug Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Aβ Monoclonal Antibody Drug by Application (2019-2030)

Figure 55. Global Revenue Market Share of Aβ Monoclonal Antibody Drug by Application (2019-2030)

Figure 56. Global Aβ Monoclonal Antibody Drug Price (US$/Unit) by Application (2019-2030)

Figure 57. Aβ Monoclonal Antibody Drug Value Chain

Figure 58. Aβ Monoclonal Antibody Drug Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions